Physiological changes caused by pregnancy have been shown to increase the risk that pregnant women infected with SARS-CoV-2 may develop obstetric complications For this reason, a group of researchers that is part of the Spanish Obstetric Emergency Group…
For some years now, the health system has been promoting changes for the assistance to pregnancy and childbirth to be less technical and interventionist, and more respectful of the right of women to decide how they want to live this experience. Although it has improved a lot…
A team from the Reproductive Medicine Service of Dexeus Women, led by Dr Piotr Sokol and Dr Elisabet Clua, has carried out a retrospective study with the aim of developing and validating a clinical prediction model to improve reproductive outcomes…
Dr Pascual García Alfaro, head of the Dexeus Women’s Menopause Unit, has led a cross-sectional study that analyses whether there is an association between endogenous hormone levels and bone mineral density in postmenopausal women.
A group of researchers led by Dr Mª Ángeles Rodríguez, expert in Prenatal Diagnosis at Dexeus Mujer, has conducted an observational study to determine the prevalence of anomalies of the corpus callosum (AbnCC) in a large population sample and to assess whether a systematic screening protocol for AbnCC should be established for…
At the XII ASEBIR Congress held in Palma last November, the candidacy of BARCELONA, led by Dr Montserrat Boada of Dexeus Mujer, was proclaimed as its candidate for the next ASEBIR Congress, a scientific society that brings together most…
From the 13th to the 16th of December 2023, the second edition of the Catalan Week of Simulation was held. This event, emblematic in its focus on clinical safety, is distinguished by the use of simulation as a fundamental tool for medical training and preparation.
Aromatase inhibitors (AI) have proven to be effective in women with hormone receptor-positive breast cancer (BC). However, the frequent appearance of stiffness and arthralgias following treatment with AIs results in a worsening of their quality of life and leads to consultations…
The Clínica Sant Josep (CSJ), managed by the Althaia Foundation, and the Dexeus Mujer group have signed an agreement to implement a new healthcare model at this hospital located in central Catalonia, which offers highly specialised medical care…
A multidisciplinary group of researchers at Dexeus Mujer have carried out an extensive study to evaluate the impact of adenomyosis in women undergoing IVF treatment. In total, a sample of 3503 patients undergoing their first…
Sentinel lymph node (SLN) biopsy has recently been accepted to assess lymph node status in early-stage endometrial cancer, which is key to tailoring adjuvant treatments. However, it is unknown to what extent…
To assess the safety and efficacy of adjuvant add-on treatments offered to improve assisted reproductive outcomes, the European Society of Human Reproduction and Embryology (ESHRE) appointed a multidisciplinary working group of clinicians…
DEXEUS CAMPUS
Gran Vía de Carles III 71-75
08028 Barcelona
campus@dexeus.com
(+34) 93 227 47 09
® Copyright 2021-2025 Dexeus Mujer Foundation – Gran Via Carles III 71-75. 08028 Barcelona. Spain
